Posterior infracoccygeal sacropexy for vaginal vault prolapse
National Institute for Clinical Excellence
Record ID 32005000336
English
Authors' objectives:
This study aims to assess the current evidence on posterior infracoccygeal sacropexy for vaginal vault prolapse.
Authors' recommendations:
1.1 Current evidence on the safety and efficacy of posterior infracoccygeal sacropexy for vaginal vault prolapse does not appear adequate for this procedure to be used without special arrangements for consent and for audit or research.
1.2 Clinicians wishing to undertake posterior infracoccygeal sacropexy should take the following actions. - Inform the clinical governance leads in their Trusts. - Ensure that patients understand the uncertainty about the procedure's safety and efficacy and are fully informed of the alternative treatment options. Patients should be provided with clear written information and use of the Institute's Information for the public is recommended. - Audit and review clinical outcomes of all patients having posterior infracoccygeal sacropexy for vaginal vault prolapse.
1.3 Further research will be useful and clinicians are encouraged to collect long-term data on clinical and quality-of-life outcomes. The Institute may review the procedure upon publication of further evidence.
Authors' methods:
Overview
Details
Project Status:
Completed
URL for project:
http://www.nice.org.uk/ipcat.aspx?c=212208
Year Published:
2005
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Gynecologic Surgical Procedures
- Uterine Prolapse
Contact
Organisation Name:
National Institute for Clinical Excellence
Contact Address:
MidCity Place, 71 High Holborn, London WC1V 6NA, UK. Tel: +44 020 7067 5800; Fax: +44 020 7067 5801
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Clinical Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.